semaglutide 0.75 mg Weight-loss drugs to be offered in generic form This extended Wegovy (semaglutide) Injector 1.7 mg/0.75

Be specific about doses and frequencies

Patient adherence may theoretically improve with patch-based delivery, as some individuals find regular injections burdensome or anxiety-provoking

Unmatched Weight Loss Magnitude Retatrutide produced up to 24% total body weight reduction in Phase 2 clinical trials a figure that exceeds every approved GLP-1 agent currently on the market, including tirzepatide (~21%) and semaglutide (~15%)

It also notes that any family history of thyroid cancer or medullary thyroid carcinoma draws additional scrutiny, because semaglutide carries a black-box warning stemming from animal thyroid studies

However, they are also beneficial for managing type 2 diabetes, cardiovascular diseases, and ensuring satiety